Nuritas Secures €2.9m Funding

26 Oct 2015 | 11.25 am

Nuritas Secures €2.9m Funding

Dr Nora Khaldi attracts Singapore venture capital

26 Oct 2015 | 11.25 am

Dublin startup Nuritas says it has secured €2.9 million in a funding round led by Singapore-based New Protein Capital, a food and agro-tech investment firm.

Nuritas was founded by Dr Nora Khaldi, a mathematician with a PhD in Molecular Evolution and Bioinformatics. The company uses artificial intelligence and DNA analysis to provide access to the most health-benefiting components within food called peptides.

Nuritas says its patented peptides unlocks ingredients from food sources in a unique way, providing natural, sustainable and scientifically proven health solutions. Nuritas has patented active therapeutics that address health challenges such as inflammation, diabetes and ageing.

Nuritas believes its peptides have a vast range of applications in multiple industries including functional and medical foods, pharmaceuticals, dietary supplements, and cosmetics and personal care.

“I was told this was impossible and I decided not to listen,” said Khaldi. “I built a team who believe in what we do and together we made it happen. We have discovered and patented some incredible life-changing ingredients and we will discover many more.”

CEO Emmet Browne (pictured with Khaldi), said: “We are delighted to collaborate with such like-minded and visionary investors to help us accelerate the discovery revolution that we have already started. With this investment we will become even better at speedily unlocking nature’s life-changing secrets that have remained hidden until now and as a result, improve global health.”

Matthieu Vermersch, founder of New Protein Capital in Singapore, commented: “Nora Khaldi and Emmet Browne, have chosen a highly innovative path to address profound consumer market challenges. From the very first discussion the harmony between our visions was obvious.”

Khaldi was a founding director of Meetingsbooker.com with Ciaran Delaney. She resigned as a director of the company in 2014.

Comments are closed.